Photodynamic therapy by topical aminolevulinic acid, dimethylsulphoxide and curettage in nodular basal cell carcinoma: a one-year follow-up study

Acta Derm Venereol. 1999 May;79(3):204-6. doi: 10.1080/000155599750010977.

Abstract

Fifty-eight patients with 119 nodular (2 mm or more in thickness) basal cell carcinomas successfully treated with photodynamic therapy were included in this 1-year follow-up study. The initial cure rate at 3-6 months was 92% after photodynamic therapy, which included an initial debulking procedure and topical application of dimethylsulphoxide in order to enhance penetration of 5-aminolevulinic acid (20% in cream) to which the lesions were exposed for 3 h prior to exposure to light. At examination 12-26 months (mean 17 months) after treatment 113 lesions (95%) were still in complete response. Six lesions (5%) had recurred, located on the face, scalp and ear. The cosmetic outcome was evaluated as excellent to good in 91%. Microscopic examination of biopsies taken from healed areas in 7 patients did not reveal any sign of damage in 5 and only minor alterations in 2.

MeSH terms

  • Administration, Topical
  • Aminolevulinic Acid / therapeutic use
  • Anti-Inflammatory Agents / therapeutic use
  • Biopsy
  • Carcinoma, Basal Cell / drug therapy*
  • Carcinoma, Basal Cell / pathology
  • Carcinoma, Basal Cell / surgery
  • Combined Modality Therapy
  • Curettage*
  • Dermatologic Surgical Procedures
  • Dimethyl Sulfoxide / therapeutic use
  • Drug Therapy, Combination
  • Follow-Up Studies
  • Humans
  • Photochemotherapy*
  • Photosensitizing Agents / therapeutic use*
  • Recurrence
  • Severity of Illness Index
  • Skin / drug effects
  • Skin / pathology
  • Skin Neoplasms / drug therapy*
  • Skin Neoplasms / pathology
  • Skin Neoplasms / surgery
  • Time Factors
  • Treatment Outcome

Substances

  • Anti-Inflammatory Agents
  • Photosensitizing Agents
  • Aminolevulinic Acid
  • Dimethyl Sulfoxide